BioCentury
ARTICLE | Politics, Policy & Law

Biden hints at executive actions on drug pricing 

Biden administration points to Medicare pilot programs, streamlining biosimilar development and possibly march-in rights to cut drug costs

September 10, 2021 1:44 AM GMT

Access This Article